BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1247286)

  • 1. Gamma globulin inhibition of fibrin clot formation.
    Davey FR; Gordon GB; Boral LI; Gottlieb AJ
    Ann Clin Lab Sci; 1976; 6(1):72-7. PubMed ID: 1247286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Disorders in the conversion of fibrinogen to fibrin in patients with multiple myeloma].
    Lopaciuk S; Snigurowicz J; Rostkowska J; Pniejnia-Olszyński W; Powiertowska-Rezmer M
    Acta Haematol Pol; 1978; 9(3):157-64. PubMed ID: 102100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired dysfibrinogenemia secondary to multiple myeloma.
    Kotlín R; Sobotková A; Riedel T; Salaj P; Suttnar J; Reicheltová Z; Májek P; Khaznadar T; Dyr JE
    Acta Haematol; 2008; 120(2):75-81. PubMed ID: 18841003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis.
    Al-Mondhiry H; Galanakis D
    J Lab Clin Med; 1987 Dec; 110(6):726-33. PubMed ID: 3119749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of fibrin monomer polymerisation by myeloma immunoglobulin.
    O'Kane MJ; Wisdom GB; Desai ZR; Archbold GP
    J Clin Pathol; 1994 Mar; 47(3):266-8. PubMed ID: 8163700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain.
    Furlan M; Stucki B; Steinmann C; Jungo M; Lämmle B
    Thromb Haemost; 1996 Sep; 76(3):377-83. PubMed ID: 8883274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of fibrinogen and fibrin on thrombin generation--evidence for feedback activation of the clotting system by clot bound thrombin.
    Kumar R; Béguin S; Hemker HC
    Thromb Haemost; 1994 Nov; 72(5):713-21. PubMed ID: 7900079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional evaluation of an inherited abnormal fibrinogen: fibrinogen "Baltimore".
    Beck EA; Shainoff JR; Vogel A; Jackson DP
    J Clin Invest; 1971 Sep; 50(9):1874-84. PubMed ID: 5564395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of an abnormal plasma clot structure by a simple rigidity assay.
    Carr ME; Blatt PM; Roberts HR; Brooker JZ; Hermans J
    Thromb Haemost; 1979 Oct; 42(3):965-71. PubMed ID: 505410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization.
    Lounes KC; Soria C; Valognes A; Turchini MF; Soria J; Koopman J
    Thromb Haemost; 1999 Dec; 82(6):1639-43. PubMed ID: 10613648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant albumin fragments that bind to fibrinogen/fibrin: possible implications.
    Galanakis DK
    Semin Thromb Hemost; 1992 Jan; 18(1):44-52. PubMed ID: 1574716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inactivation of hemostatic factors by hematin.
    Green D; Reynolds N; Klein J; Kohl H; Ts'ao CH
    J Lab Clin Med; 1983 Sep; 102(3):361-9. PubMed ID: 6411843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin polymerization defect in HIV-infected patients--evidence for a critical role of albumin in the prolongation of thrombin and reptilase clotting times.
    Toulon P; Frere E; Bachmeyer C; Candia N; Blanche P; Sereni D; Sicard D
    Thromb Haemost; 1995 Mar; 73(3):349-55. PubMed ID: 7667815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Increased thrombin time in a patient with multiple myeloma].
    Bohler A; Redondo M; Lämmle B
    Ther Umsch; 1999 Sep; 56(9):491-4. PubMed ID: 10517116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin generation and fibrin clot structure.
    Wolberg AS
    Blood Rev; 2007 May; 21(3):131-42. PubMed ID: 17208341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An acquired cryoglobulinemia which inhibits fibrin polymerization in a patient with IgG kappa myeloma.
    Panzer S; Thaler E
    Haemostasis; 1993; 23(1):69-76. PubMed ID: 8477911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of a fibrin formation abnormality in a case of multiple myeloma.
    Soria J; Soria C; Samama M; Fine JM; Bousser J
    Scand J Haematol; 1975 Oct; 15(3):207-18. PubMed ID: 812173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma.
    Carr ME; Zekert SL
    Am J Physiol; 1994 Mar; 266(3 Pt 2):H1195-201. PubMed ID: 8160823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.